Evaluation iNduction, Consolidation and Maintenance Treatment With Isatuximab , Carfilzomib, LEnalidomide and Dexamethasone
Clinical trial NCT03104842 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03104842
- Sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-15
- Primary completion
- 2026-05-01
- Enrollment
- 246
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.